News · 26 weeks630%
2026-04-192026-10-11
Mix2990d
- Insider11(38%)
- Other10(34%)
- Analyst3(10%)
- SEC Filings3(10%)
- Earnings1(3%)
- Dividends1(3%)
Latest news
25 items- PRStryker launches Sonopet® 3, delivering greater power and precision in ultrasonic tissue removalStryker has received FDA 510(k) clearance for Sonopet® 3 , the latest evolution of its ultrasonic bone and soft tissue removal platform.Developed in collaboration with surgeons, Sonopet 3 delivers enhanced power, precision and versatility.Customers gain access to advanced technologies including RISE and Pulse Control, supporting streamlined workflows and integration across surgical settings.PORTAGE, Mich., Oct. 14, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today that Sonopet 3, its latest ultrasonic bone and soft tissue removal platform, has received 510(k) clearance from the U.S. Food and Drug Administration.Developed with input from hundred
- PRStryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgeryPortage, Mich., USA and Cambridge, England, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Strategic alliance combines CMR Surgical’s established platform and robotics expertise with Stryker’s scale, customer relationships and commercial reach to accelerate growth of the Versius Surgical Robotic portfolio Stryker will make an approximately $400 million (£300 million) preferred equity investment in CMR Surgical to support future innovation and global commercialization of the Versius portfolio, subject to customary closing conditionsThe preferred equity investment also grants Stryker an exclusive option to acquire 100% of CMR Surgical’s outstanding equity in the future, subject to the agreement's term
- ANALYSTBarclays initiated coverage on Stryker with a new price targetBarclays initiated coverage of Stryker with a rating of Overweight and set a new price target of $375.00
- SECSEC Form 8-K filed by Stryker Corporation8-K - STRYKER CORP (0000310764) (Filer)
- PRStryker announces leadership successionPortage, Michigan, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Kevin Lobo to transition to Executive Chair of the Board of DirectorsCurrent President and COO Spencer Stiles appointed Chief Executive OfficerLeadership transition effective January 1, 2027 Stryker (NYSE:SYK), a global leader in medical technologies, today announced that as part of a planned succession process, Kevin Lobo will transition to the role of Executive Chair of the Board of Directors, effective January 1, 2027. Spencer Stiles, currently President and Chief Operating Officer of Stryker, will succeed Lobo as Chief Executive Officer and will also be appointed as a member of the company’s Board at that time. Lobo has led a d
- PRStryker to announce third quarter 2026 financial resultsPortage, Michigan, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, October 29, 2026, to discuss its third quarter 2026 financial results. The live webcast can be accessed at Stryker - Events & Presentations. An archive of the webcast will also be available at Stryker’s website beginning approximately two hours after the live call ends. An accompanying press release that includes summary financial information for the third quarter will be issued at approximately 4:05 p.m. (Eastern time) and available at Stryker - Press Releases on the day of the webcast. About Stryker Stryker is a global leader in medical technologies and,
- INSIDERVP, Chief Financial Officer Wells Preston Wendell disposed of 109 shares, decreasing direct ownership by 3% to 3,661 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERVP, Chief Financial Officer Wells Preston Wendell disposed of 2,739 shares, decreasing direct ownership by 42% to 3,770 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- PRStryker showcases Foot & Ankle innovation at AOFAS 2026 with Prophecy® Surgical Planning for Incompass™ and Hoffmann® LRF smartHEX™New additions advance surgical planning, implant flexibility and connected care across Stryker's Foot & Ankle portfolioStryker is launching Prophecy® Surgical Planning for the Incompass™ Total Ankle System and introducing Hoffmann®LRF smartHEX™ at the 2026 American Orthopaedic Foot & Ankle Society Annual Meeting in Seattle.Prophecy® Surgical Planning, which has supported patient-specific planning for more than 100,000 ankle cases over 14 years, is now available with the Incompass™ Total Ankle System, giving surgeons access to 3D visualization and both resect-through and pin-through fixation options within a single connected platform.Hoffmann LRF smartHEX expands Stryker's limb reconstruction
- INSIDERNew insider Baculik Emily Kay claimed ownership of 1,554 shares (SEC Form 3)3 - STRYKER CORP (0000310764) (Issuer)
- PRSchedule update: Stryker to participate in the 2026 Wells Fargo Healthcare ConferencePortage, Michigan, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor, as previously reported. Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will now participate in a fireside chat session at 10:15 a.m. (Eastern time). A simultaneous live audio webcast and replay of the session can be accessed at Stryker - Events & Presentations. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and servic
- INSIDERDirector Brainerd Mary K bought $26,736 worth of shares (131 units at $204.09) (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- PRStryker introduces first of its kind FDA-authorized surgical application for Apple Vision Pro with hip arthroscopy case at nationally recognized academic medical centerSportSuite Vision brings spatial computing into the operating room, providing surgeons access to critical clinical informationStryker announced the successful completion of the first surgical procedure, a hip arthroscopy, using SportSuite Vision on Apple Vision Pro at a leading academic medical center.Stryker received FDA De Novo authorization for the first surgical application for intraoperative use with Apple Vision Pro, SportSuite Vision.SportSuite Vision brings arthroscopic video, HipCheck, HipMap and CT imaging into a customizable spatial computing environment, helping surgeons access critical clinical information within one ergonomic field of view and streamline operating room workflow
- PRStryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offeringPortage, Mich., USA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Stryker has signed a definitive agreement to acquire ZuriMED, developer of the FiberLocker System, a commercialized technology that provides a novel approach for rotator cuff augmentation designed for increased biomechanical strength.The acquisition strengthens Stryker’s shoulder portfolio, enhancing its ability to support specialists across the continuum of care.The FiberLocker System is a soft tissue augmentation technology designed to reduce the occurrence of a key clinical failure mode in rotator cuff repair, one of the fastest-growing segments in sports medicine. Stryker (NYSE:SYK), a global leader in medical technologies, announ
- PRStryker to participate in the 2026 Wells Fargo Healthcare ConferencePortage, Michigan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor. Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will also participate in a fireside chat session at 2:15 p.m. (Eastern time). A simultaneous live audio webcast and replay of the session can be accessed at Stryker - Events & Presentations. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechn
- INSIDERGroup President Crotty Dylan Bram sold $144,915 worth of shares (441 units at $328.61) (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Stryker Ronda E sold $117,776,128 worth of shares (350,000 units at $336.50) (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDEROfficer King Debra sold $277,787 worth of shares (826 units at $336.30), decreasing direct ownership by 12% to 6,210 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- ANALYSTStryker downgraded by Wolfe ResearchWolfe Research downgraded Stryker from Outperform to Peer Perform
- PRProvidence™ Medical Technology Appoints Lane Major as President & Chief Executive OfficerAppointment builds on Providence's category leadership in Total Segmental Fusion (TSF)PLEASANTON, Calif., Aug. 6, 2026 /PRNewswire/ -- Providence Medical Technology, Inc., an innovator in differentiated spinal fusion technologies designed to improve patient outcomes, today announced that its Board of Directors has appointed Lane Major as President & Chief Executive Officer. Major also joins the company's Board of Directors. The appointment comes during a period of strong commercial momentum for Providence. Adoption of the flagship CORUS™ tissue-sparing fusion technology continues to grow across both the cervical and lumbar fusi
- PRStryker declares an $0.88 per share quarterly dividendPortage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150
- INSIDERVP, Chief Comm. Officer Montagnino Kimberly Ann covered exercise/tax liability with 155 shares, decreasing direct ownership by 8% to 1,717 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDEROfficer King Debra covered exercise/tax liability with 533 shares, decreasing direct ownership by 7% to 7,036 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERVP, Chief Legal Officer Fletcher Robert S covered exercise/tax liability with 94 shares, decreasing direct ownership by 0.89% to 10,488 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERVP, Chief HR Officer Fink M Kathryn covered exercise/tax liability with 111 shares, decreasing direct ownership by 0.84% to 13,027 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
SYK FAQ
6 questionsWhat does Stryker Corporation do?
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various...Where does SYK stock trade?
Stryker Corporation (SYK) is listed on NYSE.What sector and industry is SYK in?
Stryker Corporation operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about SYK?
Stryker Corporation has had 8 recent analyst actions on file. The most recent action was from Barclays: Overweight on 2026-10-07.What companies are similar to SYK?
Notable peers in the same industry include JNJ (Johnson & Johnson), MDT (Medtronic plc.), BDX (Becton Dickinson and Company), ZBH (Zimmer Biomet Holdings Inc.), BAX (Baxter International Inc.). Compare SYK side-by-side with any of them on Quantisnow.How can I track SYK on Quantisnow?
Quantisnow aggregates Stryker Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SYK to receive live email and push alerts on every new disclosure.